Postoperative pseudophakic bacterial endophthalmitis

American Journal of Ophthalmology
G W Zaidman, B J Mondino

Abstract

Five patients who had postoperative pseudophakic bacterial endophthalmitis were treated with topical, periocular, and systemic antibiotics. Four patients also received intravitreal antibiotics and oral corticosteroids. The causative organisms were Staphylococcus epidermidis, S. aureus, and Proteus mirabilis. Final visual acuities ranged from 6/7.5 (20/25) to no light perception. Response to treatment and final visual acuity did not appear to be related to retention or removal of the intraocular lens.

References

Aug 1, 1978·American Journal of Ophthalmology·D M EichenbaumD S Light
Nov 1, 1979·American Journal of Ophthalmology·D N GerdingM D Clark
Jan 1, 1979·International Ophthalmology Clinics·J L Tennant
Apr 1, 1978·Ophthalmology·G A PeymanM Raichand
May 1, 1977·Archives of Surgery·D B Kettlekamp
Jan 11, 1976·American Journal of Ophthalmology·R K ForsterE W Norton
Nov 1, 1974·Archives of Ophthalmology·R K Forster
Apr 1, 1980·Ophthalmology·R K ForsterH Gelender
Jun 1, 1980·Archives of Ophthalmology·T H PettitW J Martin
Sep 1, 1980·The British Journal of Ophthalmology·D J SchanzlinS I Brown

❮ Previous
Next ❯

Citations

May 1, 1984·American Journal of Ophthalmology·C M Gilbert, M A Novak
Sep 1, 1982·American Journal of Ophthalmology·G HopenJ Lipkowitz
Apr 26, 2002·Journal of Cataract and Refractive Surgery·Jyotirmay Biswas, S Krishna Kumar
Nov 21, 2000·Journal of Cataract and Refractive Surgery·M C García-SáenzA Matilla-Rodriguez
Dec 14, 1999·Survey of Ophthalmology·E J LinebargerR L Lindstrom
Apr 1, 1986·Ophthalmology·W T DriebeW W Culbertson
May 1, 1991·Journal of Cataract and Refractive Surgery·A C NeumannD J Bessinger
Jul 1, 1984·Survey of Ophthalmology·D J AppleR J Olson
Aug 1, 1987·Australian and New Zealand Journal of Ophthalmology·D M O'Day
Feb 1, 1984·Australian Journal of Ophthalmology·B A Crawford, D V Kaufman
Oct 1, 1982·American Journal of Ophthalmology·J J KanskiR Vogel
Sep 1, 1987·Journal of Cataract and Refractive Surgery·K L PiestF W Price
Oct 1, 1989·Acta Ophthalmologica·S KoulB T Philipson
Oct 1, 1989·Acta Ophthalmologica·S KoulA Philipson

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.